|
XELOX-Placebo + FOLFOX-Placebo |
XELOX-Bev + FOLFOX-Bev |
|
|
| PFS general approach |
8.0 |
9.4 |
HR 0.83 (97.5% CI 0.72–0.95), p=0.0023 |
| PFS on treatment approach |
7.9 |
10.4 |
HR 0.63 (97.5% CI 0.52–0.75), p<0.0001 |
| PFS based on IRC dataset |
8.6 |
11.1 |
HR 0.70 (97.5% CI 0.58–0.83), p<0.0001 |
|